Affiliation:
1. South Ural State Medical University of the Ministry of Health of Russia
Abstract
The article presents the results of comprehensive assessment of the efficacy of anti-IgE therapy in adult patients with severe IgE-mediated uncontrolled bronchial asthma in real clinical practice. Omalizumab added to the background anti-inflammatory therapy allowed to reduce the incidence of asthma exacerbations, achieve stable positive dynamics during severe asthma and associated allergic diseases, increase control of the disease, and improve the patients’ quality of life. The drug has a wellcharacterized long-term use safety profile.
Reference14 articles.
1. Global Strategy for Asthma Management and Prevention (2018 Update). http://ginasthma.org.
2. Bronchial asthma: clinical guidelines of the Russian Respiratory Society and the Paediatric Respiratory Society. M., 2016. spulmo.ru/download/Recommendations for BA December 2016. pdf spulmo.ru/download/Рекомендации по БА декабрь 2016.pdf.
3. Fergeson JE et al. J Allergy Clin Immunol, 2017, 139: 438.
4. Demoly P et al. Eur Respir Rev, 2010, 19. 150.
5. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm med, 2006, 6: 13.